
Pfizer Inc. – NYSE:PFE
Pfizer stock price today
Pfizer stock price monthly change
Pfizer stock price quarterly change
Pfizer stock price yearly change
Pfizer key metrics
Market Cap | 149.38B |
Enterprise value | 216.38B |
P/E | 35.41 |
EV/Sales | 3.59 |
EV/EBITDA | 15.64 |
Price/Sales | 2.50 |
Price/Book | 1.63 |
PEG ratio | 0.65 |
EPS | -0.04 |
Revenue | 55.09B |
EBITDA | 8.31B |
Income | -296M |
Revenue Q/Q | -18.61% |
Revenue Y/Y | -40.72% |
Profit margin | 7.09% |
Oper. margin | 16.85% |
Gross margin | 59.1% |
EBIT margin | 16.85% |
EBITDA margin | 15.1% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePfizer stock price history
Pfizer stock forecast
Pfizer financial statements
$32.25
Potential upside: 27.57%
Analysts Price target
Financials & Ratios estimates
Jul 2023 | 12.73B | 2.32B | 18.27% |
---|---|---|---|
Oct 2023 | 13.23B | -2.39B | -18.09% |
Dec 2023 | 14.24B | -3.34B | -23.47% |
Mar 2024 | 14.87B | 3.11B | 20.94% |
Paying a dividend greater than earnings.
Payout ratio | 221.76% |
---|
2019 | 3.89% |
---|---|
2020 | 4.13% |
2021 | 2.64% |
2022 | 3.13% |
2023 | 5.69% |
Jul 2023 | 220168000000 | 120.87B | 54.9% |
---|---|---|---|
Oct 2023 | 215021000000 | 117.81B | 54.79% |
Dec 2023 | 226501000000 | 137.21B | 60.58% |
Mar 2024 | 221095000000 | 128.53B | 58.14% |
Jul 2023 | -1.20B | -25.48B | 27.17B |
---|---|---|---|
Oct 2023 | 3.45B | 888M | -3.77B |
Dec 2023 | 5.24B | -10.99B | 5.44B |
Mar 2024 | 1.09B | 1.73B | -4.93B |
Pfizer alternative data
Pfizer Social Media Accounts
Sep 2023 | 579970 |
---|
May 2025 | 123318 |
---|---|
Jul 2025 | 123341 |
Covid 19 Vaccines
13 Aug 2023 | 3 | 3 | 5 |
---|---|---|---|
20 Aug 2023 | 7 | 5 | 3 |
27 Aug 2023 | 5 | 5 | 4 |
3 Sep 2023 | 5 | 15 | 0 |
10 Sep 2023 | 7 | 6 | 0 |
17 Sep 2023 | 3 | 4 | 0 |
24 Sep 2023 | 3 | 4 | 0 |
1 Oct 2023 | 2 | 3 | 0 |
8 Oct 2023 | 3 | 3 | 0 |
15 Oct 2023 | 2 | 7 | 0 |
22 Oct 2023 | 5 | 4 | 0 |
29 Oct 2023 | 2 | 5 | 0 |
5 Nov 2023 | 4 | 5 | 0 |
12 Nov 2023 | 33 | 21 | 0 |
19 Nov 2023 | 12 | 23 | 0 |
26 Nov 2023 | 37 | 11 | 0 |
3 Dec 2023 | 22 | 13 | 0 |
10 Dec 2023 | 44 | 12 | 0 |
17 Dec 2023 | 41 | 7 | 0 |
24 Dec 2023 | 40 | 21 | 0 |
mRNA
13 Aug 2023 | 16 |
---|---|
20 Aug 2023 | 16 |
27 Aug 2023 | 17 |
3 Sep 2023 | 19 |
10 Sep 2023 | 21 |
17 Sep 2023 | 17 |
24 Sep 2023 | 18 |
1 Oct 2023 | 17 |
8 Oct 2023 | 17 |
15 Oct 2023 | 17 |
22 Oct 2023 | 19 |
29 Oct 2023 | 15 |
5 Nov 2023 | 38 |
12 Nov 2023 | 60 |
19 Nov 2023 | 42 |
26 Nov 2023 | 80 |
3 Dec 2023 | 80 |
10 Dec 2023 | 88 |
17 Dec 2023 | 65 |
24 Dec 2023 | 60 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
Sep 2023 | 1,631 |
---|---|
Oct 2023 | 1,407 |
Nov 2023 | 1,016 |
Dec 2023 | 984 |
Jan 2024 | 1,027 |
Feb 2024 | 1,320 |
Apr 2024 | 1,321 |
May 2024 | 963 |
Jun 2024 | 945 |
Jul 2024 | 985 |
Dec 2024 | 737 |
Sep 2023 | 83,000 |
---|---|
Oct 2023 | 83,000 |
Nov 2023 | 83,000 |
Dec 2023 | 83,000 |
Jan 2024 | 83,000 |
Feb 2024 | 83,000 |
Mar 2024 | 88,000 |
Apr 2024 | 88,000 |
May 2024 | 88,000 |
Jun 2024 | 88,000 |
Jul 2024 | 88,000 |
Pfizer other data
Period | Buy | Sel |
---|---|---|
Dec 2023 | 3000 | 0 |
Aug 2024 | 0 | 5154 |
Oct 2024 | 1000 | 0 |
Patent |
---|
Grant Filling date: 23 Jan 2020 Issue date: 19 Jul 2022 |
Application Filling date: 9 Feb 2022 Issue date: 14 Jul 2022 |
Application Filling date: 9 Dec 2021 Issue date: 7 Jul 2022 |
Grant Filling date: 31 Jan 2019 Issue date: 5 Jul 2022 |
Application Filling date: 30 Apr 2020 Issue date: 30 Jun 2022 |
Application Filling date: 9 Dec 2021 Issue date: 23 Jun 2022 |
Grant Filling date: 6 Nov 2020 Issue date: 21 Jun 2022 |
Grant Filling date: 24 Sep 2018 Issue date: 21 Jun 2022 |
Grant Filling date: 8 Jun 2018 Issue date: 21 Jun 2022 |
Application Filling date: 23 Nov 2021 Issue date: 16 Jun 2022 |
Quarter | Transcript |
---|---|
Q1 2024 1 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 30 Jan 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 31 Oct 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 1 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Dr. Albert Bourla D.V.M., DVM, Ph.D. (1962) Chairman & Chief Executive Officer | $7,990,000 |
Dr. Mikael Dolsten M.D., Ph.D. (1958) Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical | $4,500,000 |
Ms. Angela Hwang (1966) Group Pres of Biopharmaceuticals Group | $3,970,000 |
Mr. John D. Young (1965) Advisor | $3,540,000 |
Why Johnson & Johnson Stock Still Has Room To Run
GSK: I Foresee Only Very Modest Upside Here Even If Blenrep Gets FDA Approval
Pfizer's Comeback Is Underway
Pfizer: Building The Next Oncology Empire
Eli Lilly: Competition Melts Away
Zoetis: Poised For Growth Yet Priced For Decline (Rating Upgrade To Strong Buy)
Takeda: Positioned To Tackle Future Clinical Demand In A Highly Regulated Sector
Why Novartis Is Still A 'Buy' After 15% Surge
Cogent: Positive Data In NonAdvSM Bodes Well For 2nd Half AdvSM Treatment Results
-
What's the price of Pfizer stock today?
One share of Pfizer stock can currently be purchased for approximately $25.28.
-
When is Pfizer's next earnings date?
Unfortunately, Pfizer's (PFE) next earnings date is currently unknown.
-
Does Pfizer pay dividends?
Yes, Pfizer pays dividends and its trailing 12-month yield is 6.31% with 222% payout ratio.It means that the company is paying a dividend greater than earnings. The last Pfizer stock dividend of $0.4 was paid on 4 Mar 2022.
-
How much money does Pfizer make?
Pfizer has a market capitalization of 149.38B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 41.7% to 58.5B US dollars.
-
What is Pfizer's stock symbol?
Pfizer Inc. is traded on the NYSE under the ticker symbol "PFE".
-
What is Pfizer's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - General industry.
-
How do i buy shares of Pfizer?
Shares of Pfizer can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Pfizer's key executives?
Pfizer's management team includes the following people:
- Dr. Albert Bourla D.V.M., DVM, Ph.D. Chairman & Chief Executive Officer(age: 63, pay: $7,990,000)
- Dr. Mikael Dolsten M.D., Ph.D. Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical(age: 67, pay: $4,500,000)
- Ms. Angela Hwang Group Pres of Biopharmaceuticals Group(age: 59, pay: $3,970,000)
- Mr. John D. Young Advisor(age: 60, pay: $3,540,000)
-
How many employees does Pfizer have?
As Jul 2024, Pfizer employs 88,000 workers.
-
When Pfizer went public?
Pfizer Inc. is publicly traded company for more then 53 years since IPO on 1 Jun 1972.
-
What is Pfizer's official website?
The official website for Pfizer is pfizer.com.
-
Where are Pfizer's headquarters?
Pfizer is headquartered at 235 East 42nd Street, New York, NY.
-
How can i contact Pfizer?
Pfizer's mailing address is 235 East 42nd Street, New York, NY and company can be reached via phone at +212 7332323.
-
What is Pfizer stock forecast & price target?
Based on 4 Wall Street analysts` predicted price targets for Pfizer in the last 12 months, the avarage price target is $32.25. The average price target represents a 27.57% change from the last price of $25.28.
Pfizer company profile:

Pfizer Inc.
pfizer.comNYSE
88,000
Drug Manufacturers - General
Healthcare
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
New York, NY 10017
CIK: 0000078003
ISIN: US7170811035
CUSIP: 717081103